首頁 > 市場調查報告書 > 製藥

婦科治療

人絨毛膜促性腺激素 (HCG) 市場：按產品類型、治療用途、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年

市場調查報告書

商品編碼

1149866

人絨毛膜促性腺激素 (HCG) 市場：按產品類型、治療用途、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年

Human Chorionic Gonadotropin Market, by Product Type, by Therapeutic Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年10月06日 | 出版商:

Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

人絨毛膜促性腺激素 (HCG) 是受精卵著床後從胎盤分泌的一種激素。它也是一種支持卵子正常發育的激素，有助於促進卵子從卵巢中釋放出來。 HCG 主要用於誘導接受生育治療的女性排卵。它也用於男性，主要是為了增加精子數量，以及當年輕男性的睪丸由於垂體疾病或其他疾病而不能自然落入陰囊時。 HCG 通常作為皮下注射劑給予肌肉。 HCG 也可以在婦科醫生或藥劑師的建議下在家使用。 HCG 水平可以在尿液和血液檢查的幫助下確定。某些測試的結果有助於確定準確的水平測量值。這些測試主要用於識別和確認懷孕或作為篩查測試以確定出生缺陷。這種激素刺激黃體產生黃體酮以維持妊娠。

市場動態

市場主要參與者越來越多地採用合作夥伴關係和收購等無機戰略，預計將在預測期內推動市場增長。例如，2021 年 1 月，科技公司 Merck & Co., Inc. 宣布與健康科技公司 Royal Philips 建立多年合作夥伴關係，為高度個性化的生育治療開發臨床級數字解決方案。宣布將開發

這項研究的主要特點

本報告對全球人絨毛膜促性腺激素 (HCG) 市場進行了深入分析，包括以 2021 年為基準年的預測期（2022-2030 年）的市場規模（百萬美元）和復合年增長率。（複合年增長率% ).
解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
它根據以下參數介紹了全球人絨毛膜促性腺激素 (HCG) 市場的主要參與者：公司亮點、產品組合、主要亮點、財務業績和戰略。
參與這項研究的主要公司包括 Merck & Co., Inc.、Ferring B.V.、Fresenius SE & Co.KGaA、Lupin、Sun Pharmaceutical Industries Ltd、Lee BioSolutions、Serum Institute of India Pvt. Ltd.、Scripps實驗室、Sanzyme Biologics Pvt. Ltd.、VHB Medi Sciences Limited、Bharat Serums And Vaccines Limited (BSV)、Zydus Lifesciences Ltd、Corona Remedies Pvt.
這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
《全球人絨毛膜促性腺激素 (HCG) 市場報告》面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者將能夠通過用於分析全球人絨毛膜促性腺激素 (HCG) 市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第二章市場展望

報告內容
- 市場定義和範圍
執行摘要
- 按產品類型劃分的市場概況
- 市場概況：按治療用途分類
- 市場概況：按銷售渠道
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 商機
影響分析
商機
影響分析
市場趨勢
主要亮點
HCG 劑型的變化
供應鏈分析
害蟲分析
概覽 - HCG 的主要治療領域
主要品牌分析和定價分析
各國使用 HCG 治療慢性疼痛的超說明書使用情況（2017 年至 2030 年）

第 4 章全球人絨毛膜促性腺激素 (HCG) 市場 - 冠狀病毒 (COVID-19) 大流行的影響

對經濟的影響
對供需的影響
COVID-19 的影響評估

第 5 章按產品類型分列的全球人絨毛膜促性腺激素 (HCG) 市場，2017-2030

人絨毛膜促性腺激素
人重組人絨毛膜促性腺激素
其他

第 6 章。全球人絨毛膜促性腺激素 (HCG) 市場：按治療用途分類，2017-2030

男性性腺功能減退症
女性不孕症治療
卵子發育不全治療
慢性疼痛治療
宮頸癌植物學處理
其他

第 7 章。全球人絨毛膜促性腺激素 (HCG) 市場：按分銷渠道，2017-2030

醫院藥房
零售藥房
在線藥店

第 8 章全球人絨毛膜促性腺激素 (HCG) 市場：按地區劃分，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
法國
意大利
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
澳大利亞
韓國
東盟
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第9章競爭格局

熱圖分析
市場份額分析
- Merck & Co., Inc.,
- Ferring B.V.
- Fresenius SE & Co.KGaA
- Lupin
- Sun Pharmaceutical Industries Ltd
- Lee BioSolutions
- Serum Institute of India Pvt. Ltd.,
- Scripps Laboratories
- Sanzyme Biologics Pvt.
- VHB Medi Sciences Limited
- Bharat Serums And Vaccines Limited
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.

第 10 章

調查方法介紹
關於出版商

簡介目錄

Product Code: CMI1011

Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.

Key features of the study:

This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.

Detailed Segmentation:

Global Human chorionic gonadotropin hormone (HCG) Market, By Product Type:
- Human Chorionic Gonadotropin
- Recombinant Human Chorionic Gonadotropin
Global Human chorionic gonadotropin hormone (HCG) Market,, By Therapeutic Application:
- Male Hypogonadism
- Female Infertility Treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
- Chronic Pain
- Others
Global Human chorionic gonadotropin hormone (HCG) Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Human chorionic gonadotropin hormone (HCG) Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Merck & Co., Inc.,*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Ferring B.V.,
- Fresenius SE & Co.KGaA
- Lupin
- Sun Pharmaceutical Industries Ltd
- Lee BioSolutions
- Serum Institute of India Pvt. Ltd.,
- Scripps Laboratories
- Sanzyme Biologics Pvt.
- VHB Medi Sciences Limited
- Bharat Serums And Vaccines Limited (BSV)
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutics Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Opportunities
Impact Analysis
Market Trends
Key Highlights
HCG Dosage Form Variation
Supply Chain Analysis
PEST Analysis
Overview- Major HCG Therapeutic Areas
Major Brand Analysis and Pricing Analysis
Off-label Usage of HCG for Chronic Pain (US$ Mn) By Country (2017-2030)

4. Global Human Chorionic Gonadotropin (HCG) Market- Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Human Chorionic Gonadotropin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Human Recombinant Human Chorionic Gonadotropin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application , 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Male Hypogonadism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Female Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Oligospermic Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Chronic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Cryptorchidism Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
North Africa
Central Africa
South Africa